A randomized, double‐blind, placebo‐controlled, multiple dose, parallel study to investigate the effects of a cathepsin S inhibitor in celiac disease
Abstract Celiac disease is a chronic, immune‐mediated enteropathy with symptoms triggered by exposure to dietary gluten in genetically predisposed individuals. The only available management option is lifelong adherence to a gluten‐free diet. This randomized, double‐blind, placebo‐controlled, paralle...
Saved in:
Main Authors: | Darren Bentley, Marie Mannino, Marianne Manchester, Priscila Camillo Teixeira, Bernhard Reis, Malcolm Boyce, Sandra Nagel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.13901 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TangBi Formula for Painful Diabetic Distal Symmetric Polyneuropathy: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled and Parallel‐Group Trial
by: Xuefei Zhao, et al.
Published: (2025-01-01) -
Retrovirus Entry by Endocytosis and Cathepsin Proteases
by: Yoshinao Kubo, et al.
Published: (2012-01-01) -
Role of Cathepsin S in Periodontal Inflammation and Infection
by: S. Memmert, et al.
Published: (2017-01-01) -
Efficacy of High-Dose and Low-Dose Simvastatin on Vascular Oxidative Stress and Neurological Outcomes in Patient with Acute Ischemic Stroke: A Randomized, Double-Blind, Parallel, Controlled Trial
by: Nattaphol Uransilp, et al.
Published: (2018-01-01) -
Safety, Tolerability and Pharmacokinetic-Pharmacodynamic Relationship of NX210c Peptide in Healthy Elderly Volunteers: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study
by: Annette Janus, et al.
Published: (2024-12-01)